President Trump is set to leave the Bethesda, Md.-based hospital at 6:30 p.m. ET, he said in the tweet, adding that he is “feeling really good.”
“Don’t be afraid of Covid. Don’t let it dominate your life. We have developed, under the Trump Administration, some really great drugs & knowledge. I feel better than I did 20 years ago!” the rest of the tweet reads.
President Trump was prescribed the steroid dexamethasone as a treatment response to his blood oxygen levels dropping twice, said White House physician Sean Conley, DO, during an Oct. 4 news briefing. The steroid is recommended for hospitalized COVID-19 patients who need oxygen or are on ventilators. This treatment development has further stirred confusion about President Trump’s condition, as his medical team said he was doing well and didn’t require supplemental oxygen as of Oct. 4, according to Dr. Conley.
However, President Trump’s medical team on Oct. 4 did acknowledge that his condition was more serious than described a day prior. After sidestepping reporters’ questions about whether the president had needed supplemental oxygen Oct. 3, Dr. Conley said President Trump did receive oxygen at the White House Oct. 2.
More articles on public health:
CDC clarifies stance on airborne COVID-19 transmission after previous mix-up
27 adults report inflammatory condition linked to COVID-19 seen in kids
28 states where COVID-19 is spreading fastest, slowest: Oct. 5
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
